These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1421683)

  • 21. Effect of potassium citrate therapy on stone recurrence and regrowth after extracorporeal shockwave lithotripsy in children.
    Sarica K; Erturhan S; Yurtseven C; Yagci F
    J Endourol; 2006 Nov; 20(11):875-9. PubMed ID: 17144854
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urinary citrate and renal stone disease: the preventive role of alkali citrate treatment.
    Caudarella R; Vescini F
    Arch Ital Urol Androl; 2009 Sep; 81(3):182-7. PubMed ID: 19911682
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RECENT ADVANCES IN CHEMICAL PROTECTION AGAINST RADIATION INJURY.
    VANDENBRENK HA
    J Coll Radiol Australas; 1963 Oct; 7():222-6. PubMed ID: 14074378
    [No Abstract]   [Full Text] [Related]  

  • 24. Evaluation of the radioprotective effect of Liv 52 in mice.
    Jagetia GC; Ganapathi NG; Venkatesh P; Rao N; Baliga MS
    Environ Mol Mutagen; 2006 Aug; 47(7):490-502. PubMed ID: 16758471
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radioprotective effects of DNA ligands Hoechst-33342 and 33258 in whole body irradiated mice.
    Singh SP; Jayanth VR; Chandna S; Dwarakanath BS; Singh S; Adhikari JS; Jain V
    Indian J Exp Biol; 1998 Apr; 36(4):375-84. PubMed ID: 9717448
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protection of mouse chromosomes against whole-body gamma irradiation by SH-compounds.
    Gupta R; Uma Devi P
    Br J Radiol; 1986 Jun; 59(702):625-7. PubMed ID: 3011178
    [No Abstract]   [Full Text] [Related]  

  • 27. Whole body protection against lethal ionizing radiation in mice by REC-2001: a semi-purified fraction of Podophyllum hexandrum.
    Lata M; Prasad J; Singh S; Kumar R; Singh L; Chaudhary P; Arora R; Chawla R; Tyagi S; Soni NL; Sagar RK; Devi M; Sharma RK; Puri SC; Tripathi RP
    Phytomedicine; 2009 Jan; 16(1):47-55. PubMed ID: 17574826
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of mucopolysaccharide sulfation using rabbit liver sulfotransferases.
    Foye WO; Kulapaditharom V
    J Pharm Sci; 1985 Mar; 74(3):355-8. PubMed ID: 3159883
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [New treatment of obese rheumatics; sulfur-amphetamine association].
    JUNET R
    Rev Med Suisse Romande; 1952 Jan; 72(1):45-51. PubMed ID: 14930541
    [No Abstract]   [Full Text] [Related]  

  • 30. Urinary macromolecules and renal tubular cell protection from oxalate injury: comparison of normal subjects and recurrent stone formers.
    Tsujihata M; Tsujikawa K; Tei N; Yoshimura K; Okuyama A
    Int J Urol; 2006 Mar; 13(3):197-201. PubMed ID: 16643608
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Mode of action and indication for appetite depressants in the treatment of obesity].
    Stauffacher W
    Schweiz Med Wochenschr; 1975 Apr; 105(15):461-6. PubMed ID: 1124373
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Recurrence of upper urinary tract calculi].
    Mitsuhashi S; Hikage T; Kawamura K; Masukagami T; Matsuzaki A
    Hinyokika Kiyo; 1988 Sep; 34(9):1549-55. PubMed ID: 3213791
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 5,7-Dihydroxychromone-2-carboxylic acid and it's transition-metal (Mn and Zn) chelates as non-thiol radioprotective agents.
    Hosseinimehr SJ; Emami S; Taghdisi SM; Akhlaghpoor S
    Eur J Med Chem; 2008 Mar; 43(3):557-61. PubMed ID: 17602799
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hidden amphetamines: from smoking cessation to diabetes.
    Prescrire Int; 2004 Feb; 13(69):18-20. PubMed ID: 15055218
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of amphetamine as an appetite depressant.
    GALLAGHER NI; KNIGHT WA
    J Chronic Dis; 1958 Aug; 8(2):244-52. PubMed ID: 13563605
    [No Abstract]   [Full Text] [Related]  

  • 36. Electrophoretic separation and characterization of urinary glycosaminoglycans and their roles in urolithiasis.
    Gohel MD; Shum DK; Tam PC
    Carbohydr Res; 2007 Jan; 342(1):79-86. PubMed ID: 17145044
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimum nutrition for kidney stone disease.
    Heilberg IP; Goldfarb DS
    Adv Chronic Kidney Dis; 2013 Mar; 20(2):165-74. PubMed ID: 23439376
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolic assessment of recurrent and first renal calcium oxalate stone formers.
    Çakıroğlu B; Eyyupoğlu E; Hazar AI; Uyanik BS; Nuhoğlu B
    Arch Ital Urol Androl; 2016 Jul; 88(2):101-5. PubMed ID: 27377084
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of specific markers for amphetamines synthesized from glycidic acid pre-precursors and retrospective search in German profiling database.
    Hauser FM; Pütz M; Rößler T; Hulshof JW
    Drug Test Anal; 2020 Jan; 12(1):41-52. PubMed ID: 31471943
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Time- and dose-dependent post-irradiation changes of Fe3+-transferrin and Cu2+-ceruloplasmin pools in blood, their influence on ribonucleotide reductase activity in animal tissues and the effects of radioprotectors].
    Sharygin VL; Pulatova MK; Shliakova TG; Todorov IN
    Radiats Biol Radioecol; 2003; 43(6):662-77. PubMed ID: 14963934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.